Subscribe to our Newsletters !!

    COPD

    Aerogen – bringing a lower risk of transmission of patient generated infectious aerosol for healthcare professionals in acute care settings compared to traditional nebulisers

    India has 18% of the global population and an increasing burden of chronic respiratory diseases1. The technique of nebulisation is commonly utilised in the treatment of such diseases including asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD)2. Recent improvements in nebuliser technologies have led to the development of vibrating mesh nebulisers (VMNs) that produce

    Aerogen: An appropriate aerosol drug delivery system for the effective treatment of respiratory illness

    No matter what the respiratory illness, for mechanically ventilated or spontaneous breathing patients, Aerogen has the appropriate aerosol drug delivery system for the effective treatment of your patients. The illness includes: 1.COPD 2.Asthma 3.Cystic Fibrosis COPD Chronic Obstructive Pulmonary Disease (COPD) is among the very serious lung diseases prevalent today affecting 65 million people globally.

    Pharmaceutical Roots: Guaifenesin – a gift from the ‘Tree of Life’

    Pharmaceutical Roots is a content series from LGC Mikromol investigating and outlining the natural origins of pharmaceutical substances, and offering a deeper dive into their uses, risks, and mechanisms of action. Introduction Worth close to $100 million in sales each year, and a staple ingredient in some of the world’s most trusted medicines for many